Experience
Mylan Pharmaceuticals Inc.
Senju Pharmaceutical Co., Ltd.; Bausch & Lomb Incorporated
Assisted in representing Senju Pharmaceutical and others in inter partes review proceedings relating to ophthalmic drug Bepreve®.
Mylan Pharmaceuticals Inc. v. Senju Pharmaceutical Co., Ltd.; Bausch & Lomb Incorporated, IPR2016-00626, -01163, PTAB, Judges Bonilla, Green, Mitchell
InnoPharma Licensing, Inc.; Lupin Ltd.; and Metrics, Inc. v. Senju Pharmaceuticals Co.
Bausch Health Companies
Hartig Drug Co. Inc. v. Senju Pharmaceutical Co. Ltd.
Senju Pharmaceuticals Co. Ltd.
Senju Pharmaceutical Co., Ltd. v. Apotex Inc.
Senju Pharmaceutical Co., Ltd.; Bausch + Lomb Inc.
Mylan Pharmaceuticals Inc. v. Bausch Health Ireland Ltd.
Bausch Health Ireland Ltd.
Housey Pharmaceuticals, Inc. v. Otsuka Pharmaceutical Co. Ltd.
Otsuka Pharmaceutical Co. Ltd.
Senju Pharmaceutical Co.; Bausch + Lomb v. Lupin Ltd.
Senju Pharmaceutical Co.; Bausch + Lomb
Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.
Otsuka Pharmaceutical Co.
Mylan Pharmaceuticals Inc. et al. v. Biogen MA Inc. et al.
Biogen MA Inc. et al.
Apotex Inc. v. Senju Pharmaceutical
Senju Pharmaceuticals Co. Ltd.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.